After Biontech and Moderna: New mRNA vaccine promises advantages
–
–
After Biontech and Moderna: New mRNA vaccine promises advantages
After a successful clinical study, a new mRNA vaccine from the US manufacturer Arcturus Therapeutics promises a surprising advantage over the previously approved vaccines from Moderna or Biontech/Pfizer.
show description
The RKI reports further falling corona numbers. The Stiko calls on certain people to have a fourth vaccination. More in the Corona blog.
–
–
Media report: Lauterbach makes a proposal for a triage regulation
US restricts access to Johnson & Johnson vaccine
The RKI reports further declining corona numbers on Friday
The nationwide incidence is 553.2
The Standing Committee on Vaccination urges certain people to get the fourth vaccination as soon as possible
According to the RKI weekly report, omicron subvariant BA.2 continues to grow
Berlin. The number of new corona infections in Germany continues to fall. On Friday, the number of new infections reported was 85,073 – up from 101,610 in the previous week. The nationwide seven-day incidence was 553.2. According to the Robert Koch Institute (RKI) was 566.8 (previous week: 758.5; previous month: 1322.2). More on this: Corona in Germany – An overview of the current figures from the RKI
Meanwhile, the Standing Vaccination Commission has warned against waiting for vaccines adapted to the omicron variant. Vulnerable groups such as seniors and people with Pre-existing illness should already be given the fourth vaccination, Stiko chairman Klaus Mertens told this editorial office. According to Federal Minister of Health Karl Lauterbach, a previous infection with the omicron variant does not protect or only slightly against infection with the omicron subtypes BA.4 and BA5. This increases the likelihood of new ones waves of infection in the fall, according to the SPD politician.
Morning post from Christine Richter
Order the editor-in-chief’s daily newsletter for free here
–
articlebody:textmodule) –>
Corona news from Friday, May 6th: Media report: Lauterbach makes a proposal for a triage regulation
7.34 am: According to a media report, if there is a shortage of capacity in clinics, it should also be legally possible in the future to treat a person in intensive care in favor of a patient with a higher chance of survival cancel. This comes from a revised legislative proposal by Health Minister Karl Lauterbach (SPD) for the protection of people with disabilities in a so-called Triage-Situation out, reports the “RedaktionsNetzwerk Deutschland” (Friday). The Federal Constitutional Court had called for legal triage regulations in view of the corona pandemic.
This so-called ex-post triage should proposed law However, this can only be permissible if three specialists with experience in intensive care medicine make the decision by mutual agreement. According to the draft, the approval of two specialists is sufficient for ex-ante triage, in which the decision on treatment must be made between several newly admitted patients in a situation of scarce medical capacities. Lauterbach’s proposal is currently being coordinated with the other departments.
US restricts access to Johnson & Johnson vaccine
7.13 a.m.: The US Food and Drug Administration has restricted access to Johnson & Johnson’s Covid vaccine. In the future, only adults will receive the vaccine, the more effective ones mRNA vaccines cannot or will not receive from Biontech/Pfizer or Moderna, the FDA said on Thursday. The reason for the change in the emergency approval of the vaccine is the increased risk of severe blood clots.
For the same reason, the FDA had already recommended in December to be treated preferentially with the mRNA vaccines. The J&J vaccine hardly plays a role in the USA anyway: only three percent of all injected Corona-Impfdosen come from J&J subsidiary Janssen. Despite this, “we recognize that Janssen’s Covid vaccine still has a role to play in responding to the current pandemic,” FDA chief Peter Marks said.
Stiko boss Mertens: Fourth vaccination for vulnerable groups urgently needed
5:56 a.m.: The chairman of the Standing Vaccination Committee (Stiko), Thomas Mertens, has urged older people and people with previous illnesses to get a fourth vaccination against the corona virus: “We have to expect that the risk of infection will increase again in autumn,” Mertens told this editorial office. People over 70 and others with special risk for a serious illness should therefore use the time now to improve their protection with a fourth vaccination. There is now more data that shows that a second booster is very useful for this group. Older and other risk groups should not wait for a vaccine adapted to the omicron variant to come, says Mertens.
The Stiko chairman expressed skepticism about a fourth vaccine dose for everyone, but mentioned one exception: “In the event that a variant should appear, it should be clear sickening is as Omicron and possibly even Delta, a fourth vaccination could be necessary for everyone in autumn,” says Mertens. Basically, however, I do not believe that the entire population has to be vaccinated against the corona virus again and again in order to prevent infections “However, it is likely that we will have to regularly vaccinate those who are at risk of developing serious illness after an infection against which the available vaccines already provide good protection.”
articlebody:textmodule) –>
RKI reports numbers – incidence continues to fall
5.35 a.m.: The Robert Koch Institute (RKI) has the nationwide seven-day incidence quoted as 553.2 on Friday morning. This is evident from numbers that reflect the status of the RKI dashboard at 5 a.m. The day before, the value of new infections per 100,000 inhabitants and week was 566.8 (previous week: 758.5 previous month: 1322.2).
The health authorities in Germany reported 85,073 to the RKI Corona neoinfections (previous week: 101,610 registered infections) and 214 deaths (previous week: also 214) within one day. Comparisons of the data are only possible to a limited extent due to the test behavior, late registrations or transmission problems. In general, the number of registered new infections and deaths varies significantly from weekday to weekday, as more and more federal states do not transmit to the RKI, especially at weekends, and report their cases later in the week.
articlebody:textmodule) –>
Corona news from Thursday, May 5: Omicron subvariant BA.2 is still increasing – other variants are still rare
8:20 p.m.: According to data from the Robert Koch Institute (RKI), the omicron subvariant BA.2, which has been dominating in Germany for weeks, has recently increased again. According to the latest findings – a sample from the week before last – their share was almost 98 percent, as shown in the RKI weekly report on Thursday evening. The subtype BA.1, which was previously responsible for most corona infections, is therefore only less than two percent, the relatively new omicron sublines BA.4 and BA.5 have so far played a subordinate role according to the data.
BA.4 is listed with a share of 0.1 percent, BA.5 with 0.3 percent. Mixed variants have “so far only been proven in isolated cases,” it says. In Deutschland only a small number of positive samples have their genome completely examined. Also read: How will we get through the next Corona autumn?
In the weekly report, the RKI experts also state that the seven-day incidence in the past week has fallen further compared to the previous one – namely by 19 percent. The number of people treated in an intensive care unit with a Covid 19 diagnosis has also continued to fall, and the number of deaths has also decreased. “The infection pressure remains high with almost 600,000 Covid 19 cases transmitted to the RKI within the last week,” they warn. Vaccination is still of great importance with its strong protective effect against severe courses.
articlebody:textmodule) –>
EMA expects Omicron vaccines to be approved by September
3.45 p.m.: According to the European Medicines Agency (EMA), vaccines against the highly contagious omicron variant of the coronavirus could be approved by the end of September at the latest. The greatest chances are there for accordingly customized mRNA vaccines of the companies Moderna and Biontech, said the EMA director for vaccination strategy Marco Cavaleri on Thursday at a press conference of the authority in Amsterdam.
The necessary clinical studies are in progress. The EMA is also checking preparations from other manufacturers. However, it is “no secret” that the adaptations of mRNA vaccines from Moderna and Biontech to Omikron are already quite advanced. He did not give details of the study data collected so far.
articlebody:textmodule) –>
WHO: Estimated 15 million deaths in corona pandemic
3:23 p.m.: According to estimates by the WorldHealth Organization (WHO), around 14.9 million people died in connection with Covid-19 between January 2020 and December 2021. The WHO announced on Thursday in Geneva that these were deaths caused directly and indirectly by the corona virus.
Indirectly, people died from Covid-19 during the pandemic because overburdened health systems had to forego the treatment of certain other diseases. According to WHO Director-General Tedros Adhanom Ghebreyesus, the “sobering data” illustrate the need to invest in health systems. In crisis situations, essential health services should be able to be maintained.
A new Corona blog starts here. All previous Corona news can be found here.
